tradingkey.logo
tradingkey.logo
Search

Summit Therapeutics Inc

SMMT
Add to Watchlist
13.105USD
-0.555-4.06%
Close 07-27 16:00ETQuotes delayed by 15 min
10.39BMarket Cap
LossP/E TTM

SMMT Financials

See Summit Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Summit Therapeutics Inc Earnings Date

Latest Release
Jul 23, 2026
EPS / Forecast
-0.28/-0.28
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.44
-368.77%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
63.61%-0.28
-186.57%-0.24
-1640.23%-1.44
-302.78%-0.31
-793.06%-0.76
-37.59%-0.09
-59.16%-0.08
-153.97%-0.08
-304.46%-0.09
95.68%-0.06
47.59%-0.05
---0.03
---0.02
---1.43
---0.10
---0.52
----
----
----
----
Revenue
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-83.19%220.00K
312.28%235.00K
30.21%250.00K
35.68%251.00K
623.20%1.31M
Net Profit
61.87%-215.70M
-201.09%-189.42M
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.37%-61.20M
-164.50%-56.25M
-310.31%-60.38M
91.98%-43.47M
-90.17%-36.57M
0.55%-21.27M
12.25%-14.72M
-2434.82%-542.38M
29.04%-19.23M
-9.11%-21.39M
31.31%-16.77M
-22.35%-21.40M
-101.60%-27.10M
-10.46%-19.60M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---8447.23%
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
-100.00%0.00%
-89.36%4.87%
-30.56%29.25%
44.19%56.57%
-36.37%49.27%
--45.77%
--42.13%
--39.23%
--77.44%
----
----
----
----
----
Revenue
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-83.19%220.00K
312.28%235.00K
30.21%250.00K
35.68%251.00K
623.20%1.31M
Operating profit
61.21%-220.50M
-192.01%-195.21M
-241.73%-224.93M
-303.02%-234.21M
-1169.71%-568.44M
-56.92%-66.85M
-80.88%-65.82M
-179.97%-58.11M
-184.16%-44.77M
-153.87%-42.60M
-188.24%-36.39M
-14.28%-20.76M
-16.69%-15.76M
29.65%-16.78M
57.29%-12.62M
22.05%-18.16M
51.66%-13.50M
-15.78%-23.85M
-84.58%-29.55M
-25.00%-23.30M
Net Profit
61.87%-215.70M
-201.09%-189.42M
-258.11%-219.17M
-312.05%-231.79M
-836.84%-565.71M
-44.72%-62.91M
-67.37%-61.20M
-164.50%-56.25M
-310.31%-60.38M
91.98%-43.47M
-90.17%-36.57M
0.55%-21.27M
12.25%-14.72M
-2434.82%-542.38M
29.04%-19.23M
-9.11%-21.39M
31.31%-16.77M
-22.35%-21.40M
-101.60%-27.10M
-10.46%-19.60M
Current assets
133.02%720.58M
66.31%616.60M
69.98%720.30M
-49.73%246.47M
-5.95%309.24M
127.09%370.75M
123.36%423.75M
139.22%490.29M
44.52%328.79M
-34.17%163.26M
-71.11%189.71M
49.47%204.95M
186.53%227.50M
149.44%248.03M
574.85%656.71M
34.15%137.12M
-34.64%79.40M
-20.59%99.44M
10.99%97.31M
142.91%102.21M
Total current liabilities
71.68%103.57M
138.74%83.27M
74.91%72.99M
10.03%64.93M
-56.96%60.33M
48.81%34.88M
104.50%41.73M
-48.12%59.01M
1074.82%140.17M
34.37%23.44M
-47.39%20.41M
581.82%113.74M
-21.37%11.93M
-23.24%17.44M
51.36%38.78M
-26.80%16.68M
-30.68%15.17M
-68.89%22.72M
28.82%25.62M
54.59%22.79M
Total assets
132.13%752.18M
68.79%647.86M
72.46%751.18M
-47.95%261.73M
-5.21%324.04M
117.12%383.82M
114.62%435.56M
130.16%502.85M
44.02%341.86M
-30.65%176.78M
-69.44%202.95M
40.66%218.48M
147.99%237.37M
118.85%254.90M
485.82%664.17M
20.71%155.33M
-34.22%95.72M
-17.27%116.47M
10.61%113.37M
126.28%128.67M
Total liabilities
89.17%122.20M
158.09%101.92M
97.22%92.32M
6.98%69.47M
-55.99%64.60M
-70.21%39.49M
-62.63%46.81M
-45.48%64.93M
24.63%146.78M
9.19%132.57M
-76.70%125.26M
439.41%119.10M
165.25%117.77M
133.20%121.42M
1686.35%537.51M
-16.29%22.08M
70.18%44.40M
-31.84%52.06M
30.57%30.09M
31.85%26.38M
Total equity
142.83%629.98M
58.55%545.93M
69.48%658.86M
-56.10%192.26M
32.99%259.44M
678.85%344.33M
400.37%388.75M
340.66%437.92M
63.11%195.07M
-66.88%44.21M
-38.66%77.69M
-25.42%99.38M
133.06%119.60M
107.25%133.48M
52.07%126.65M
30.25%133.25M
-57.03%51.32M
0.00%64.41M
4.82%83.28M
177.52%102.30M
Net operating income
-111.44%-141.12M
-99.93%-122.29M
-109.43%-101.94M
-207.23%-93.08M
-102.24%-66.74M
-102.99%-61.17M
-150.13%-48.67M
-103.38%-30.30M
-12.74%-33.00M
-129.49%-30.13M
-474.86%-19.46M
-74.13%-14.90M
-52.33%-29.27M
30.89%-13.13M
156.55%5.19M
63.70%-8.55M
-0.22%-19.22M
8.07%-19.00M
-15.15%-9.18M
-41.54%-23.57M
Net investment
47.80%222.90M
-100.15%-238.00K
-681.15%-485.16M
99.93%-71.00K
175.37%150.81M
705.75%160.11M
37.83%83.48M
-3015.75%-108.61M
-96756.52%-200.08M
103.08%19.87M
605580.00%60.57M
-17530.00%-3.49M
170.65%207.00K
-178587.81%-645.06M
108.33%10.00K
400.00%20.00K
-94.04%-293.00K
-825.64%-361.00K
-140.00%-120.00K
109.09%4.00K
Net financing
10299.55%231.08M
-50.54%3.80M
2530.21%573.82M
-83.44%33.81M
-98.89%2.22M
1482.89%7.68M
-477.67%-23.61M
89044.98%204.14M
250365.00%200.21M
-99.39%485.00K
-98.80%6.25M
-99.69%229.00K
---80.00K
218.07%80.11M
41141.87%520.06M
10994.23%75.00M
-100.00%0.00
-54.94%25.19M
-97.51%1.26M
--676.00K

FAQs

What are the current assets of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its current assets were 720.30M, with a year-on-year change of 69.98.

What are the total assets of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its total assets of Summit Therapeutics Inc were 751.18M, with a year-on-year change of 72.46.

What are the total liabilities of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its total liabilities of Summit Therapeutics Inc were 92.32M, with a year-on-year change of 97.22.

What is the total equity of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its total equity of Summit Therapeutics Inc was 658.86M, with a year-on-year change of 69.48.

What is the net operating income of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its net operating income of Summit Therapeutics Inc was -1.09B, with a year-on-year change of -417.94.

What is the net investment of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its net investment of Summit Therapeutics Inc was -174.31M, with a year-on-year change of 15.11.

What is the net financing of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its net financing of Summit Therapeutics Inc was 617.53M, with a year-on-year change of 61.99.

What is the Earnings Per Share (EPS) of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.44, with a year-on-year change of -368.77.

What is the net income of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its net income was -1.08B, with a year-on-year change of -387.81.

What is the Return on Equity (ROE) of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -206.10, with a year-on-year change of -117.19.

What is the Return on Assets (ROA) of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -181.94, with a year-on-year change of -162.46.

What is the operating profit of Summit Therapeutics Inc?

According to Summit Therapeutics Inc's FY2025 earnings report, its operating profit was -1.09B, with a year-on-year change of -417.94.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.